Form 4 for TECH Bio-Techne
Accepted 2026-08-18 16:42:33 ET · period of report 2026-08-15 · accession 0000914190-26-000116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-18 16:42 | 2026-08-15 | TECH | Bohnen Shane | SVP - GC | M - OptEx | $0.00 | +4,350 | 11.7K | +59% | $0 |
| D | 2026-08-18 16:42 | 2026-08-15 | TECH | Bohnen Shane | SVP - GC | F - Tax | $72.40 | -1,343 | 10.4K | -11% | -$97.2K |
| DM | 2026-08-18 16:42 | 2026-08-15 | TECH | Bohnen Shane | SVP - GC | M - OptEx | $0.00 | -4,350 | 4,664 | -48% | $0 |
| DM | 2026-08-18 16:42 | 2026-08-15 | TECH | Bohnen Shane | SVP - GC | D - Sale to Iss | $0.00 | -16.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-15 | M | A | 4,350 | $0.00 | 11,703 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-15 | F | D | 1,343 | $72.40 | 10,360 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-08-15 | M | D | 49 | $0.00 | 0 | D | — · — to — | 49 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F5) 49 restricted stock units vest on 8/15/2026. (F5) 49 restricted stock units vest on 8/15/2026. |
| 4 | Derivative | Performance Stock Option (Right to Buy) | 2026-08-15 | D | D | 12,117 | $0.00 | 807 | D | $84.61 · — to — | 12,117 Common Stock | (F6) On 8/15/2026, the Board of Directors authorized discretionary vesting for 807 performance options. The remainder of the performance options were forfeited. (F6) On 8/15/2026, the Board of Directors authorized discretionary vesting for 807 performance options. The remainder of the performance options were forfeited. |
| 5 | Derivative | Performance Restricted Stock Units | 2026-08-15 | M | D | 300 | $0.00 | 4,502 | D | — · — to — | 300 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F7) On 8/15/2026, the Board of Directors authorized discretionary vesting for 300 performance RSUs. The remainder of the performance RSUs were forfeited. (F7) On 8/15/2026, the Board of Directors authorized discretionary vesting for 300 performance RSUs. The remainder of the performance RSUs were forfeited. |
| 6 | Derivative | Performance Restricted Stock Units | 2026-08-15 | D | D | 4,502 | $0.00 | 0 | D | — · — to — | 4,502 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F7) On 8/15/2026, the Board of Directors authorized discretionary vesting for 300 performance RSUs. The remainder of the performance RSUs were forfeited. (F7) On 8/15/2026, the Board of Directors authorized discretionary vesting for 300 performance RSUs. The remainder of the performance RSUs were forfeited. |
| 7 | Derivative | Restricted Stock Units | 2026-08-15 | M | D | 1,669 | $0.00 | 1,669 | D | — · — to — | 1,669 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F9) 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. (F9) 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. |
| 8 | Derivative | Restricted Stock Units | 2026-08-15 | M | D | 2,332 | $0.00 | 4,664 | D | — · — to — | 2,332 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F12) 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. (F12) 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. |